Questions discussed in this category
If a patient has received a kidney transplant for SLE-LN and is stable and doing well. Managed by their transplant team and on chronic immunosuppressi...
The case prompting the question is a female in her late teens who was diagnosed with Class IV LN at her prepubescent age and was treated with HCQ and ...
How do you monitor response and what do you consider a satisfactory response? Do you aim for a certain threshold of proteinuria?
Do you refer all patients with suspected LN, patients with confirmed LN, or patients with specific features (not responding to usual therapy, certain ...
21309212162000720006192111473215003
Papers discussed in this category
Rheumatic diseases clinics of North America, 2006 Feb
The New England journal of medicine, 1986 Mar 06
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2003
Annals of the rheumatic diseases, 2023 Oct 12
Kidney international, 2024 Jan
Lupus, 2023 Sep 27
Arthritis & rheumatology (Hoboken, N.J.), 2023 Jul 19
Clinical transplantation, 2020 Nov 22
Arthritis care & research, 2023 Nov 28